Page 16 - Abstract Book ICOH4
P. 16

5

            Development and evaluation of vaccines against Vibrio harveyi in orange-spotted grouper,
                                               Epinephelus coioides

                                                   Shih Chu Chen

                                                      Abstract


                 Vaccination  is  the  best  strategic  to  prevention  infectious  diseases.  Vibrio  harveyi  is  a  major  bacterial
          pathogen that causes serious vibriosis in cultured groupers, so considerable efforts are in practice to control the
          pathogen. In the present study, we developed and evaluated the immune responses and protective efficacy of
          inactivated  and  recombinant  outer  membrane  protein  (rOMP)  vaccines  against  V.  harveyi  in  orange-spotted
          groupers. The vaccine candidates were (1) V. harveyi formalin-killed cells (FKC) plus Montanide  ISA 763 AVG, (2)
                                                                                          TM
          V. harveyi FKC combined with CpG ODN 1668-enriched plasmids (p30CpG and p60CpG), and (3) V. harveyi rOMPs
          in addition to Montanide  ISA 763 AVG. Antibody titers were significantly elevated in the vaccinated fish. A pivotal
                              TM
          observation was that the vaccine highly protected the grouper from a homologous V. harveyi strain challenge with
          relative  percentage  survival  values  of  100%  and  91.7%  at  6  and  12  weeks  post-immunization,  respectively.
          Vaccinated fish also demonstrated strong cross-protection against a heterologous V. harveyi isolate challenge. The
          vaccines containing V. harveyi FKC and CpG ODN 1668-enriched plasmids stimulated remarkably greater antibody
          titers in vaccinated fish 2 weeks post-immunization. The relative percent survival after V. harveyi challenge was
          significantly higher in FKC + p60CpG-vaccinated fish (96.2%) than in FKC + p30CpG-vaccinated (79.8%) and FKC-
          vaccinated  fish  (59.9%).  Notably,  an  enhanced  immune  response  and  significant  protective  efficacy  against  V.
          harveyi infections were observed in the fusion protein vaccine-injected fishes with relative percent survival value of
          81.8%. Additionally, the rOmpK-OmpU antisera presented a high bactericidal effect on not only V. harveyi, but also
          V. parahaermolyticus and V. alginolyticus.

          Keywords: V. harveyi, vaccines, immune responses, protective efficacy, orange-spotted grouper











          THE 4  INTERNATIONAL CONFERENCE ON ONE HEALTH (ICOH)
              TH

          “Strengthening Collaboration in One Health Systems”
   11   12   13   14   15   16   17   18   19   20   21